Cipla wins Frost & Sullivan and TERI’s Sustainability 4.0 Award

13 Jan 2022 Evaluate

Cipla has been awarded winner as a “Challenger in Mega Large Business Pharma Sector” by Frost & Sullivan and TERI’s Sustainability 4.0 Awards. The award is a testimony to Cipla’s continuous efforts in the Environment, Social & Governance (ESG) space as a leader in the pharma industry. The company has been selected from a list of 50 reputed companies nominated for this award.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1518.80 7.85 (0.52%)
05-Jan-2026 14:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1730.00
Dr. Reddys Lab 1249.85
Cipla 1518.80
Zydus Lifesciences 919.65
Lupin 2079.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×